Navigation Links
Xytis Names Gordon H. Busenbark as Chief Financial Officer
Date:10/19/2007

IRVINE, Calif., Oct. 19 /PRNewswire/ -- Xytis Inc., a privately held biotechnology company focused on developing novel therapeutics to treat central nervous system (CNS) diseases, today announced that Gordon H. Busenbark has joined the company as Chief Financial Officer. Mr. Busenbark has more than 25 years of experience in the pharmaceutical, biotechnology and medical devices industries. During a 23 year career at Baxter Healthcare, Mr. Busenbark held a number of senior-level financial, operational and general management positions in both the U.S. and Europe. This included roles as Chief Financial Officer of Immuno AG when the company was acquired by Baxter, and President of Baxter's global Plasma Therapeutics business. Mr. Busenbark's most recent role was as Chief Financial Officer at Encysive Pharmaceuticals, where his accomplishments included raising more than $100 million in debt and equity financing.

"We are very pleased to have Gordon join Xytis," said Vincent F. Simmon, CEO and President. "He brings great financial and operational experience, both from a large pharmaceutical company perspective as well as from that of a smaller biotechnology company. Gordon joins us at an exciting time for Xytis. Our Phase 2 clinical trial in Traumatic Brain Injury (TBI) is approximately half way enrolled. Also, there is considerable partnering interest in two of our pre-clinical programs; positive allosteric modulators of GABA-A receptor and of alpha-7 nicotinic acetylcholine receptors. His experience and assistance in financing and marshalling these programs forward will be greatly welcomed."

Mr. Busenbark has both a B.S. in Accounting and an MBA from the University of Utah.

About Xytis

Xytis Inc. is a privately held discovery and development biopharmaceutical company, headquartered in Irvine, California, and having a clinical development group in Nyon, Switzerland, focused on innovative CNS drug candidates. The Company's investors include At
'/>"/>

SOURCE Xytis Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... -- The Pharmaceutical Care Management Association (PCMA) issued ... offsets included in the Energy & Commerce Committee,s ... 21st Century Cures initiative can only be advanced by ... Medicare – then its costs outweigh any potential ... "Leveraging payments to Part D plans to ...
(Date:5/21/2015)...  Heidrick & Struggles (Nasdaq: HSII ), the ... consulting and culture shaping worldwide, strengthens ... announcing the addition of Tim Dietlin to ... Dietlin has extensive life sciences and professional ... Medical and Commercial functions to increase productivity, drive transformational ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 Research ... announced the addition of the "Global Next ... offering. The global next generation sequencing ... over the period 2014-2019 This report ... of the global next generation sequencing market for ...
Breaking Medicine Technology:Heidrick Increases Healthcare and Life Sciences Expertise 2Global Next Generation Sequencing Market 2015-2019 2
... Annual Meeting- , , ... of a randomized phase III study presented at the ... The study in adult patients with hematological malignancies at ... demonstrated that Elitek(R) (rasburicase) significantly reduced plasma uric acid ...
... Analgesic Significantly Reduces Postop Pain, Opioid Use, and ... Standard Pain Medication , ... A Phase II dose escalation study of a ... who underwent total knee arthroplasty, or TKA, showed ...
Cached Medicine Technology:Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 2Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 3Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 4Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 5Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 2Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 3Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 4
(Date:5/22/2015)... 2015 Power Systems is proud to announce ... race season. Drobeck is in his second year of racing ... with the Missoula Fire Department in Missoula, MT. He entered ... 2014. During his career, he has had 15 1st Place ... top 10 finishes in all seven of his 2014 races, ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all ... company specialize in include decks, additions, kitchen remodeling, interior ... much more. , The redesigned logo is a ... company. It includes two geometrical lines that represent the ... to be used with many things associated with the ...
(Date:5/22/2015)... 2015 DMG Productions announces the upcoming ... broadcast on Friday, May 29, 2015 at 7:30 a.m. ... In this episode Innovations will explore Interstate Restoration, a ... quickly through disaster recovery and restoration. , Additionally, the ... collaboratively to develop and deliver training and education in ...
(Date:5/22/2015)... May 22, 2015 Co founders Greenlee and ... to allow general dentists to immediately deliver fully integrated dental ... on that of the medical surgeon. , The Center, ... roadblocks preventing general dentists from placing dental implants. These ... steps to introduce the surgical placement of dental implants into ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The ... letter calling on religious leaders to make changes in order ... on his blog, discusses the history of war, how it ... it. Yisrayl says mankind was created to lead peaceful, joyful ... society. , “Yahweh created mankind, according to His Plan, ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2
... Center is one of only 10 pediatric hospitals in the ... U.S.News & World Report,s America,s Best Children,s Hospitals ... serve children, 56 were ranked, and only an elite 10 ... coveted Honor Roll. The specific service lines surveyed included cancer, ...
... three national organizations representing nearly a third of a ... their continued concern for America,s patients who do not ... of Family Physicians (AAFP), the American College of Physicians ... majority of physicians who care for Medicare patients. The ...
... Members of Congress Seek Oncology Best Practices as First Step ... 18 U.S. Representatives Rep. Artur Davis (D-AL), Steve Israel ... the Medicare Quality Cancer Care Demonstration Act of 2009. ... to direct the Centers for Medicare & Medicaid Services (CMS) ...
... ... leadership must be strengthened and expanded at the individual, institutional, and network levels, Accordia ... ... outcomes in Africa over the long term, the continent’s healthcare leadership must be strengthened ...
... treatment of type 2 diabetes is not scientifically proven. Nor ... form, such as metformin and sulfonylureas. As a result, there ... been approved for 10 years and nateglinide for 8 years ... of longer duration than 14 months. This is the conclusion ...
... Nuu Rainforest Spring Water launches in the United States with several ... Appointments have already been set with several major distributors, ... having already approved the line for distribution , ... there is a place where nature shines. The ancient tribe ...
Cached Medicine News:Health News:Children's Named Among the Nation's Top 10 Pediatric Hospitals by U.S.News & World Report 2Health News:Call for primary care reform from AAFP, ACP and AOA 2Health News:Call for primary care reform from AAFP, ACP and AOA 3Health News:Call for primary care reform from AAFP, ACP and AOA 4Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 2Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 3Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 4Health News:Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 2Health News:Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 3Health News:Benefit of glinides is not proven 2Health News:Benefit of glinides is not proven 3Health News:Next Generation Waters - Nuu 2
... Plates feature a unique design for easy ... CP titanium and .3mm thick for ease ... optimal malleability. Universal (left/right) anatomical shape for ... and smooth construction for optimal safety. Four ...
... Brown nucleus cracker with straight shaft ... viscoelastic, thereby, maintains anterior chamber depth ... Accomplished with a design that keeps ... blocking outflow of viscoelastic. Available with ...
Epilation forceps angled ends size 3.5"....
Forceps, delicate, straight....
Medicine Products: